Treatment of confirmed B12 deficiency in hemodialysis patients improves Epogen® requirements

International Journal of Nephrology and Renovascular Disease

Volumn 6, Issue , 2013, Pages 89-93

  Saifan, Chadi ^a   Samarneh, Mark ^a   Shtaynberg, Norbert ^a   Nasr, Rabih ^a   El Charabaty, Elie ^a   El Sayegh, Suzanne ^a  

^a STATEN ISLAND UNIVERSITY HOSPITAL   (United States)

Author keywords

Anemia; Chronic kidney disease; Dialysis; End stage renal disease; Erythropoietin; ESRD; Vitamin deficiency

Indexed keywords

CYANOCOBALAMIN; HEMOGLOBIN; METHYLMALONIC ACID; RECOMBINANT ERYTHROPOIETIN;

ADULT; ARTICLE; BLOOD LEVEL; BLOOD SMEAR; CONTROLLED STUDY; CYANOCOBALAMIN DEFICIENCY; DISEASE ASSOCIATION; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HEMODIALYSIS PATIENT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PATIENT MONITORING; QUALITY OF LIFE; TREATMENT DURATION; VITAMIN SUPPLEMENTATION;

EID: 84878769846     PISSN: None     EISSN: 11787058     Source Type: Journal    
DOI: 10.2147/IJNRD.S44660     Document Type: Article

References (11)

1. Foley RN, Curtis BM, Parfrey PS. Erythropoietin therapy, hemoglobin targets, and quality of life in healthy hemodialysis patients: a randomized trial. Clin J Am Soc Nephrol. 2009;4(4):726-733.
2. Tefferi A, Pruthi RK. The biochemical basis of cobalamin deficiency. Mayo Clin Proc. 1994;69(2):181-186.
3. Stabler SP, Lindenbaum J, Allen RH. The use of homocysteine and other metabolites in the specific diagnosis of vitamin B-12 deficiency. J Nutr. 1996;126(4):1266S-1272S.
4. van Guldener C. Why is homocysteine elevated in renal failure and what can be expected from homocysteine-lowering? Nephrol Dial Transplant. 2006;21(5):1161-1166.
5. Khoueiry G, Waked A, Goldman M, et al. Dietary intake in hemodialysis patients does not reflect a heart healthy diet. J Ren Nutr. 2011;21(6):438-447.
6. Herrmann W, Schorr H, Geisel J, Riegel W. Homocysteine, cystathionine, methylmalonic acid and B-vitamins in patients with renal disease. Clin Chem Lab Med. 2001;39(8):739-746.
7. Moelby LK, Rasmussen K, Rasmussen H. Serum methylmalonic acid in uraemia. Scand J Clin Lab Invest. 1992;52(4):351-354.
8. Moelby L. Rasmussen K, Ring T, Nielsen G. Relationship between methylmalonic acid and cobalamin in uremia. Kidney Int. 2000;57(1): 265-273.
9. Hvas AM, Juul S, Gerdes LU, Nexo E. The marker of cobalamin deficiency, plasma methylmalonic acid, correlates to plasma creatinine. J Intern Med. 2000;247(4):507-512.
10. Johnson DW, Pollock CA, Macdougall IC. Erythropoiesis-stimulating agent hyporesponsiveness. Nephrology (Carlton). 2007;12(4): 321-330.
11. Zachee P, Chew SL, Daelemans R, Lins RL. Erythropoietin resistance due to vitamin B12 deficiency. Case report and retrospective analysis of B12 levels after erythropoietin treatment. Am J Nephrol. 1992; 12(3):188-191.